4
Views
1
CrossRef citations to date
0
Altmetric
CaseReport Article

The successful treatment of a gender dysphoric patient with Pimozide

&
Pages 422-425 | Published online: 06 Jul 2009

References

  • Bancroft J. Sexual disorders. Companion to psychiatric studies. 5th ed, RE Kendell, AK Zealley. Churchill Livingstone, Edinburgh 1993; 553–575
  • Munro A. Monosymptomatic hypochondriacal psychosis. British Journal of Hospital Medicine 1980; 24: 34–38
  • Kenyon FE. Hypochondriacal states. British Journal of Psychiatry 1976; 129: 1–14
  • Munro A. Paranoia revisited. British Journal of Psychiatry 1982; 141: 344–349
  • Riding J, Munro A. Pimozide in the treatment of mono-symptomatic hypochondriacal psychosis. Acta Psychiatrica Scandinavica 1975; 52: 23–30
  • Reilly TM, Jopling WH, Beard AW. Successful treatment with pimozide of delusional parasitosis. British Journal of Dermatology 1978; 98: 457–459
  • Dorian BJ. Monosymptomatic hypochondriacal psychosis [letter]. Canadian Journal of Psychiatry 1979; 24: 377
  • Munro A, O'Brien J, Ross D. Two cases of ‘pure’ or ‘primary’ erotomania successfully treated with pimozide. Canadian Journal of Psychiatry 1985; 30: 619–622
  • Mackay AVP. Antischizophrenic drugs. Drugs in psychiatric practice. London: Butterworths, PJ Tyrer, 1982; 42–81
  • DeLisi LE. The significance of age of onset for schizophrenia. Schizophrenia Bulletin 1992; 18: 209–215

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.